127 related articles for article (PubMed ID: 37084522)
1. Degeneration of nigrostriatal dopaminergic neurons in the early to intermediate stage of dementia with Lewy bodies and Parkinson's disease.
Okitsu M; Sugaya K; Nakata Y; Kawazoe T; Ikezawa J; Okiyama R; Takahashi K
J Neurol Sci; 2023 Jun; 449():120660. PubMed ID: 37084522
[TBL] [Abstract][Full Text] [Related]
2. Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders.
Kawazoe T; Sugaya K; Nakata Y; Okitsu M; Takahashi K
Clin Park Relat Disord; 2024; 10():100242. PubMed ID: 38405025
[TBL] [Abstract][Full Text] [Related]
3. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a
Pilotto A; Schiano di Cola F; Premi E; Grasso R; Turrone R; Gipponi S; Scalvini A; Cottini E; Paghera B; Garibotto V; Rizzetti MC; Bonanni L; Borroni B; Morbelli S; Nobili F; Guerra UP; Perani D; Padovani A
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1642-1651. PubMed ID: 31098748
[TBL] [Abstract][Full Text] [Related]
4. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
[TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
Walker Z; Costa DC; Walker RW; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona CL
Neurology; 2004 May; 62(9):1568-72. PubMed ID: 15136683
[TBL] [Abstract][Full Text] [Related]
6. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
7. Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson's Disease (PD) and dementia with Lewy bodies (DLB).
Lanfranchi F; Arnaldi D; Miceli A; Mattioli P; D'Amico F; Raffa S; Donegani MI; Chiola S; Massa F; Pardini M; Di Raimondo T; Sambuceti G; Bauckneht M; Nobili F; Morbelli S
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1090-1102. PubMed ID: 36471041
[TBL] [Abstract][Full Text] [Related]
8. Striatal dopamine transporter degeneration in right-handed REM sleep behavior disorder patients progresses faster in the left hemisphere.
Miyamoto T; Akaiwa Y; Numahata K; Yoshizawa K; Sairenchi T; Miyamoto M
Parkinsonism Relat Disord; 2022 Feb; 95():107-112. PubMed ID: 35093712
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
10. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
[TBL] [Abstract][Full Text] [Related]
11.
Kasanuki K; Iseki E; Ota K; Kondo D; Ichimiya Y; Sato K; Arai H
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):358-365. PubMed ID: 27480759
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.
Walker Z; Costa DC; Walker RW; Shaw K; Gacinovic S; Stevens T; Livingston G; Ince P; McKeith IG; Katona CL
J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):134-40. PubMed ID: 12122169
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
[TBL] [Abstract][Full Text] [Related]
14. Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
Martín-Bastida A; Lao-Kaim NP; Roussakis AA; Searle GE; Xing Y; Gunn RN; Schwarz ST; Barker RA; Auer DP; Piccini P
Brain; 2019 Jul; 142(7):2023-2036. PubMed ID: 31056699
[TBL] [Abstract][Full Text] [Related]
15. Imaging of the nigrostriatal system for evaluating the preclinical phase of Parkinson's disease development: the utility of neuromelanin, diffusion MRI, and DAT-SPECT.
Takahashi H; Kashiwagi N; Arisawa A; Matsuo C; Kato H; Adachi H; Kajiyama Y; Mochizuki H; Tomiyama N
Br J Radiol; 2022 Feb; 95(1130):20210837. PubMed ID: 34808066
[TBL] [Abstract][Full Text] [Related]
16. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
[TBL] [Abstract][Full Text] [Related]
17. Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease.
Kim HK; Kim T; Baek MS; Kim EY; Sung YH; Lee JH; Ryu YH; Ahn SJ; Yoo HS; Lyoo CH
Eur J Neurol; 2023 Jun; 30(6):1639-1647. PubMed ID: 36915220
[TBL] [Abstract][Full Text] [Related]
18. Lower
Joling M; Vriend C; van der Zande JJ; Lemstra AW; van den Heuvel OA; Booij J; Berendse HW
Neuroimage Clin; 2018; 19():130-136. PubMed ID: 30035010
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease.
Ransmayr G; Seppi K; Donnemiller E; Luginger E; Marksteiner J; Riccabona G; Poewe W; Wenning GK
Eur J Nucl Med; 2001 Oct; 28(10):1523-8. PubMed ID: 11685496
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
